2025 CPT code 90670

Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use

This code represents the product only; a separate code for the immunization administration (e.g., 90460, 90461, 90471-90474) must also be reported. For SARS-CoV-2 vaccine administration, use 90480. Do not report 90476-90759 with 90480 unless both a SARS-CoV-2 vaccine and another vaccine from 90476-90759 are given at the same encounter.

Medical necessity for PCV13 is based on the patient's age, underlying health conditions, and risk factors for pneumococcal disease.Specific guidelines exist for different age groups and risk categories.

The clinician is responsible for assessing the patient's suitability for the vaccine, administering the vaccine intramuscularly using proper technique, counseling the patient or family about potential side effects and the vaccination schedule, and documenting the administration appropriately.

In simple words: This is a shot that helps protect babies, young kids, and sometimes older people or those with health problems, from infections caused by pneumococcal bacteria, such as pneumonia, infections in the blood, and meningitis (an infection around the brain and spinal cord).

This code represents the administration of the Pneumococcal 13-valent Conjugate Vaccine (PCV13), specifically for intramuscular injection.This vaccine protects against 13 strains of Streptococcus pneumoniae bacteria which can cause various illnesses including pneumonia, meningitis, and sepsis.It is routinely administered to infants and young children as a series of four doses, but it may also be given to older children and adults with certain health conditions or risk factors.

Example 1: A 6-month-old infant receives their third dose of PCV13 during a well-child visit., A 25-year-old adult with sickle cell disease receives a dose of PCV13., A 70-year-old adult receives a dose of PCV13 for added protection against pneumococcal disease.

Documentation should include the date of administration, vaccine manufacturer and lot number, site and route of administration, and any adverse reactions. Patient consent and education provided should also be documented.

** This vaccine does not protect against all serotypes of pneumococcal bacteria.Patients may still develop pneumococcal disease even after vaccination.

  • Specialties:Pediatrics, Family Medicine, Internal Medicine, Geriatrics, Infectious Disease
  • Place of Service:Office, Inpatient Hospital, Outpatient Hospital
** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.